WHO ICTRP trial
Study to Evaluate the Effect of "Huashi Runzao Formula" Combined with…
ChiCTR2200061608 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200061608 |
|---|---|
| Public title | Study to Evaluate the Effect of "Huashi Runzao Formula" Combined with Guideline-Directed Medical Treatment on the Quality of Life and Clinical Outcomes in Patients with Sjogren's Syndrome: a Clinical Trial on Constructing a Novel Paradigm of Integrated Traditional Chinese and Western Medicine in the Treatment |
| Scientific title | Study to Evaluate the Effect of "Huashi Runzao Formula" Combined with Guideline-Directed Medical Treatment on the Quality of Life and Clinical Outcomes in Patients with Sjogren's Syndrome: a Clinical Trial on Constructing a Novel Paradigm of Integrated Traditional Chinese and Western Medicine in the… |
| Primary sponsor | China-Japan Friendship Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Primary Sjogren's syndrome |
| Interventions | Group A:Huashi Runzao Formula 200mL bid po;Group B:Hydroxychloroquine sulfate tablets 200mg bid po;Group C:Huashi Runzao Formula Placebo 200mL bid po;Group D:Hydroxychloroquine sulfate tablets 200mg bid po |
| Registration date | Jun 29, 2022 |
| Target size | Group A:59;Group B:59;Group C:59;Group D:59 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: